Cambridge Investment Research Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CNBS Stock Details CNBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,337	Closed	-$179K	–	3428
2024 Q2	$179K	Sell	3,337 -35	-1%	-$2.17K	﹤0.01%	3068
2024 Q1	$233K	Buy	3,372 +308	+10%	+$18.1K	﹤0.01%	2895
2023 Q4	$157K	Sell	3,064 -1	-0%	-$49	﹤0.01%	2958
2023 Q3	$177K	Buy	3,065 +457	+18%	+$23.6K	﹤0.01%	2855
2023 Q2	$116K	Buy	2,608 +272	+12%	+$12.7K	﹤0.01%	2976
2023 Q1	$118K	Buy	2,336 +695	+42%	+$41.1K	﹤0.01%	2938
2022 Q4	$100K	Buy	1,641 +261	+19%	+$20.2K	﹤0.01%	2903
2022 Q3	$96K	Buy	1,380 +486	+54%	+$41.2K	﹤0.01%	2863
2022 Q2	$71K	Buy	+894	New	+$96.8K	﹤0.01%	2905
2021 Q3	–	Sell	-657	Closed	-$203K	–	3112
2021 Q2	$203K	Sell	657 -2,235	-77%	-$698K	﹤0.01%	2820
2021 Q1	$1.01M	Buy	2,892 +1,503	+108%	+$507K	0.01%	1429
2020 Q4	$291K	Buy	+1,389	New	+$251K	﹤0.01%	2165

Other funds holding CNBS

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

GWP

Gateway Wealth Partners Appleton, Wisconsin $1.67B AUM 21.55% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $2.01B AUM 31.39% 1-Year Est. Return

Cambridge Investment Research Advisors's CNBS Position: Q3 2024 in Review

Cambridge Investment Research Advisors sold out of Amplify Seymour Cannabis ETF (CNBS) in Q3 2024, closing a stake of 3,337 shares — an estimated $179K sold.

Cambridge Investment Research Advisors first reported a position in CNBS in Q4 2020 and held it in 12 quarters. The position peaked at $1.01M in Q1 2021. 27 funds tracked by Wall St. Rank hold CNBS as of Q3 2024.

Cambridge Investment Research Advisors reported no remaining Amplify Seymour Cannabis ETF position as of Q3 2024 after selling out during the quarter.
Cambridge Investment Research Advisors sold 3,337 Amplify Seymour Cannabis ETF shares in Q3 2024, an estimated $179K.
Cambridge Investment Research Advisors first reported a position in Amplify Seymour Cannabis ETF in Q4 2020 and held it in 12 quarters.
Cambridge Investment Research Advisors's Amplify Seymour Cannabis ETF position peaked at $1.01M in Q1 2021.
27 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q3 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.